Dentsply Sirona (XRAY) Tops Q3 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
Price: $11.38 --0%
Revenue Growth %: -4.2%
Financial Fact:
Selling, general and administrative expenses: 379.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -4.2%
Financial Fact:
Selling, general and administrative expenses: 379.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Dentsply Sirona (NASDAQ: XRAY) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $951 million versus the consensus estimate of $937.91 million.
GUIDANCE:
Dentsply Sirona sees FY2024 EPS of $1.82-$1.86, versus the consensus of $1.98.
For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Mizuho Downgrades Essex Property Trust (ESS) to Neutral 'on valuation'
- Mizuho Upgrades Vivmark Residential (VMRK) to Outperform, 'relatively favorable GARP profile'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
